Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBPε Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index; 15 of the 82 sources its claims cite were checked for support.
Abstract
GATA-1 and the ets factor PU.1 have been reported to functionally antagonize one another in the regulation of erythroid versus myeloid gene transcription and development. The CCAAT enhancer binding protein epsilon (C/EBPepsilon) is expressed as multiple isoforms and has been shown to be essential to myeloid (granulocyte) terminal differentiation. We have defined a novel synergistic, as opposed to antagonistic, combinatorial interaction between GATA-1 and PU.1, and a unique repressor role for certain C/EBPepsilon isoforms in the transcriptional regulation of a model eosinophil granulocyte gene, the major basic protein (MBP). The eosinophil-specific P2 promoter of the MBP gene contains GATA-1, C/EBP, and PU.1 consensus sites that bind these factors in nuclear extracts of the eosinophil myelocyte cell line, AML14.3D10. The promoter is transactivated by GATA-1 alone but is synergistically transactivated by low levels of PU.1 in the context of optimal levels of GATA-1. The C/EBPepsilon(27) isoform strongly represses GATA-1 activity and completely blocks GATA-1/PU.1 synergy. In vitro mutational analyses of the MBP-P2 promoter showed that both the GATA-1/PU.1 synergy, and repressor activity of C/EBPepsilon(27) are mediated via protein-protein interactions through the C/EBP and/or GATA-binding sites but not the PU.1 sites. Co-immunoprecipitations using lysates of AML14.3D10 eosinophils show that both C/EBPepsilon(32/30) and epsilon(27) physically interact in vivo with PU.1 and GATA-1, demonstrating functional interactions among these factors in eosinophil progenitors. Our findings identify novel combinatorial protein-protein interactions for GATA-1, PU.1, and C/EBPepsilon isoforms in eosinophil gene transcription that include GATA-1/PU.1 synergy and repressor activity for C/EBPepsilon(27).
Overview
CoChat Summary
TL;DR
This paper defines a novel synergistic, rather than antagonistic, interaction between GATA-1 and PU.1 at the eosinophil MBP-P2 promoter, and identifies C/EBPε27 as a repressor of GATA-1 and GATA-1/PU.1 transactivation. It also shows that C/EBPε32/30 and C/EBPε27 physically interact with PU.1 and GATA-1 in eosinophil cell lysates.
Key findings
- The MBP-P2 promoter contains two GATA, two C/EBP, and two PU.1 consensus sites; GATA-1 bound the dual GATA sites, PU.1 bound both PU.1 sites, and C/EBPβ/C/EBPε bound the first C/EBP site in AML14.3D10 nuclear extracts.
- GATA-1 alone induced MBP-P2 activity ~20-fold, while GATA-1 plus low PU.1 induced ~60-fold; in another assay GATA-1/PU.1 synergy was ~75-fold. High PU.1 abrogated synergy, and mutation of the PU.1 sites had essentially no effect, indicating protein-protein interaction rather than direct PU.1 DNA binding.
- C/EBPε27 strongly repressed GATA-1 transactivation and completely blocked GATA-1/PU.1 synergy, while C/EBPε32 and C/EBPε14 did not; C/EBPε27 also blocked PU.1-mediated M-CSFR transactivation.
- Co-immunoprecipitation showed C/EBPε32/30 and C/EBPε27 physically interact with PU.1 and GATA-1 in AML14.3D10 lysates; C/EBPε14 was not co-immunoprecipitated. In C/EBPε null mice, MBP mRNA was only partially decreased (~50%), whereas C/EBPα null mice showed no detectable MBP expression.
Methods
- Binding was assessed by EMSA and antibody supershift assays using nuclear extracts from AML14.3D10 eosinophil myelocytes, AML14 parental myeloblasts, and mature peripheral blood eosinophils (>99% purity).
- Functional analyses used MBP-P2 luciferase reporter constructs with mutated GATA, C/EBP, or PU.1 sites in CV-1 cells and by transient transfection/electroporation in AML14 and AML14.3D10 cells; K562 cells were used for endogenous GATA-1 context.
- Protein interactions were tested by Western blotting and co-immunoprecipitation from AML14.3D10 whole-cell lysates; MBP mRNA in C/EBPα- and C/EBPε-deficient mice was measured by semi-quantitative RT-PCR with GAPDH normalization.
Limitations
- The paper states that the GATA-1 null mutation in the mouse had not been evaluated for eosinophil development, though a note added in proof cites a later report of selective eosinophil loss after deletion of a high-affinity GATA-binding site.
- The paper states that PU.1 could not be co-immunoprecipitated with C/EBPε or GATA-1, possibly because endogenous PU.1 is low in AML14.3D10 cells or because antibodies blocked interactions.
- The paper notes that murine C/EBPε encodes only a single full-length 34-kDa isoform, with no murine equivalents of the human 27- and 14-kDa isoforms, suggesting human versus murine differences; evident from the text, the mechanistic model relies heavily on heterologous CV-1 overexpression and cell lines, and in vivo occupancy studies were still in progress.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
10 Valid · 0 Not valid · 30 Not checked · 100 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“This finding suggests that GATA-1 expression is significantly down-regulated during eosinophil terminal differentiation, supporting prior results in the avian system (2, 7).”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > PU.1, GATA-1, and C/EBP⑀ Isoforms Are Differentially Expressed in Eosinophilic Cell Lines and Mature Blood Eosinophils and Bind to the Their Consensus Sites in the Functional
What the sources say
- Could not verifycites [2] McNagny, 1998, EMBO J. sourceExperimental — accuracy not yet measured
Our copy of McNagny et al. (1998) contains no measurement or statement of GATA-1 expression changing during eosinophil terminal differentiation; searched for 'GATA-1 levels decrease during eosinophil differentiation', 'down-regulation of GATA-1 expression ... time course', and 'GATA-1 protein levels in eosinophils 1A1 cells'. What the paper does report (sections 'Biphasic regulation of the EOS47 promoter by GATA-1' and 'GATA-1: both an activator and a repressor of the EOS47 promoter') is that GATA-1 is expressed and binds the EOS47 GATA site in 1A1 eosinophils, that low/intermediate GATA-1 activates and high GATA-1 represses the EOS47 promoter, and that ectopic GATA-1 dose specifies lineage commitment in myeloblasts — i.e. a dosage-dependence point, not a down-regulation-during-differentiation result. The only 'down-regulation' in these passages concerns myeloid markers after GATA-1-ER activation, which is the opposite direction of the attributed claim, so the source neither supports nor contradicts it. (LLM, conf=0.70)
- Not checked yetcites [7] Kulessa, 1995, Genes Dev. source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“and C/EBP⑀ in particular) are essential for the commitment and/or terminal differentiation of myeloid progenitors to the eosinophil lineage (1)(2)(3)(4)(5)(6)(7)(8)(9).”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > Abstract
What the sources say
- Partly supportedcites [1] Nerlov, 1998, Genes Dev. sourceExperimental — accuracy not yet measured
The paper states that eosinophils, at least in chickens, require C/EBP and moderate GATA-1 levels (section labeled Abstract; page unavailable). Its results show that brief PU.1 activation produces cells with properties of immature eosinophils, not that PU.1 is essential for their terminal differentiation. The cited passages also do not establish the claim specifically for C/EBPα and C/EBPε. (LLM, conf=0.86)
- Partly supportedcites [2] McNagny, 1998, EMBO J. sourceExperimental — accuracy not yet measured
The section ‘A role for C/EBPs and Ets-1/Fli-1 in eosinophil differentiation’ (page not supplied) reports that C/EBPα-deficient mice lack mature eosinophils, while leaving open whether the defect is in commitment or terminal differentiation. The GATA-1 discussion links its expression level to lineage commitment. The copy does not establish that PU.1 or C/EBPε is essential for either step in the eosinophil lineage. (LLM, conf=0.87)
- Partly supportedcites [3] Nerlov, 1998, Genes Dev. sourceExperimental — accuracy not yet measured
The Abstract reports that C/EBPα and C/EBPβ induce eosinophil differentiation in multipotent progenitors, and it describes eosinophil-maturation defects in C/EBPα and C/EBPε knockout mice. In “Role of GATA-1 in myeloid/eosinophil lineage choice,” the authors propose that intermediate GATA-1 helps specify eosinophils, but their model directs PU.1 toward a myeloid fate, not an essential role in eosinophil commitment or maturation. The claim also presents these factors as definitively essential where parts of the paper’s account are tentative. (LLM, conf=0.88)
- Not checked yetcites [4] Yamanaka, 1997, Proc. Natl. Acad. Sci. U. S. A. source
- Partly supportedcites [5] Muller, 1995, EMBO J. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that activating NF-M, the chicken C/EBPβ homolog, induced eosinophilic markers in a progenitor cell line and suggests it causes eosinophilic lineage commitment. It also proposes a role for GATA-1 alongside NF-M, but does not establish that these factors are essential. The cited passages do not support the claim about PU.1, C/EBPα, or C/EBPε being essential for eosinophil differentiation. (LLM, conf=0.88)
- Not checked yetcites [6] van Dijk, 1998, Blood source
- Not checked yetcites [7] Kulessa, 1995, Genes Dev. source
- Not checked yetcites [8] Yamaguchi, 1998, Blood source
- Not checked yetcites [9] Yamaguchi, 1999, Blood source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The C/EBP⑀ 27 isoform contains both transactivation and putative repression domains (40,61,63).”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > PU.1, GATA-1, and C/EBP⑀ Isoforms Are Differentially Expressed in Eosinophilic Cell Lines and Mature Blood Eosinophils and Bind to the Their Consensus Sites in the Functional
What the sources say
- Partly supportedcites [40] Lekstrom-Himes, 1998, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The paper’s discussion of C/EBPε isoforms (page unavailable) says they have variably truncated activation domains and differing transcriptional activities. It does not identify a 27-kDa isoform or say that this isoform contains a putative repression domain; its discussion of activation and repression domains concerns C/EBPs generally. (LLM, conf=0.82)
- Partly supportedcites [61] Yamanaka, 1997, Proc. Natl. Acad. Sci. U. S. A. sourceExperimental — accuracy not yet measured
The Results identify a 27.8-kDa C/EBPε isoform, but do not describe its transactivation or putative repression domains. The functional tests in Results examined only the 32.2- and 14.3-kDa isoforms, so they do not establish the claimed domain combination for the 27.8-kDa isoform. (LLM, conf=0.82)
- Not checked yetcites [63] Williamson, 1998, J. Biol. Chem. source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C/EBP␣-deficient (null) mice show a selective block in the differentiation of granulocytes (both neutrophils and eosinophils) beyond the myeloblast stage (52)”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > DISCUSSION
What the sources say
- Supportedcites [52] Zhang, 1997, Proc. Natl. Acad. Sci. U. S. A. source
The ABSTRACT states that C/EBPα-targeted disruption mice 'demonstrate a selective block in differentiation of neutrophils,' that 'mature neutrophils and eosinophils are not observed in the blood or fetal liver of mutant animals' while other lineages including monocytes are unaffected, and that most peripheral white cells 'had the appearance of myeloid blasts' — i.e. arrest at the blast stage. The DISCUSSION reiterates a 'selective block in the development of mature granulocytes' along the granulocytic lineage with normal myeloid precursors (GEMM-CFU/GM-CFU unaffected), and the INTRODUCTION frames the relevant transition as from bipotential progenitor myeloblasts to unipotent granulocyte precursors. Both the granulocyte (neutrophil + eosinophil) scope and the beyond-myeloblast localization are therefore in our copy. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“By comparison, mice with a targeted disruption of the C/EBP␣ gene have a profound absence of both neutrophils and eosinophils in the fetal liver (52).”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > PU.1, GATA-1, and C/EBP⑀ Isoforms Are Differentially Expressed in Eosinophilic Cell Lines and Mature Blood Eosinophils and Bind to the Their Consensus Sites in the Functional
What the sources say
- Supportedcites [52] Zhang, 1997, Proc. Natl. Acad. Sci. U. S. A. source
The abstract of our copy states directly that mice with targeted disruption of the CCAAT enhancer binding protein α gene show a selective block in neutrophil differentiation and that 'Mature neutrophils and eosinophils are not observed in the blood or fetal liver of mutant animals,' which matches the attributed claim including the fetal-liver site and the absence of both cell types. The Results (Fig. 1 legend and p. 7 passage) corroborate the absence of mature granulocytes in newborn and embryonic day 14/19 fetal livers, and the Discussion confirms the block is selective to the granulocytic lineage. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
74 more claims · 4 with their cited sources checked
Create a free account to see all 140 claims and to verify the 67 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 51
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, C/EBP family members C/EBP-ɛ and C/EBP-β, were found to antagonize both GATA-1 transactivation and GATA-1/PU.1 synergistic activation of the eosinophil MBP-P2 promoter, as well as PU.1-mediated transactivation of PU.1 target genes/promoters such as the M-CSFR, suggesting a potent repressor function for this isoform in myeloid development [95].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [95]
In the citing paper
“Key combinatorial interactions of GATA-1, PU.1 and C/EBP-δ isoforms mediate either synergy or antagonism of eosinophil gene transcription during myeloid development and terminal differentiation [95].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > DNA Constructs and Mutagenesis-
“Promoter activities were determined using the Dual-luciferase Reporter Assay System (Promega) 48 h after transfection.”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > DISCUSSION
“Luciferase activity was assayed 72 h after transfection.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > PU.1, GATA-1, and C/EBP⑀ Isoforms Are Differentially Expressed in Eosinophilic Cell Lines and Mature Blood Eosinophils and Bind to the Their Consensus Sites in the Functional
“Two specific complexes formed with the first C/EBP consensus site using nuclear extract of AML14.3D10eosinophils (lane 1, bands  and ⑀).”
§ Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBP⑀ Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* > PU.1, GATA-1, and C/EBP⑀ Isoforms Are Differentially Expressed in Eosinophilic Cell Lines and Mature Blood Eosinophils and Bind to the Their Consensus Sites in the Functional
“Antibody to C/EBP⑀ completely removed and supershifted complex ⑀ and partially removed complex ⑀ (lane 8).”
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S.-F., D'Agati, V., Orkin, S. H., & Costantini, F. (1991) · Nature · doi:10.1038/349257a0 · Cited by 1,308
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Research works printed but not linked: 7
- Zhang, 1996, Curr. Top. Microbiol. Immunol., 211, 137
- Perez, 1994, Mol. Cell. Biol., 14, 5023
- Simon, 1996, Curr. Top. Microbiol. Immunol., 211, 113
- Paul, 1997, Am. J. Hematol., 56, 79, 10.1002/(sici)1096-8652(199710)56:2 · doi:10.1002/(sici)1096-8652(199710)56:2
- Sun, 1996, Curr. Top. Microbiol. Immunol., 211, 173
- Evans, 1991, Mol. Cell. Biol., 11, 843
- Yamanaka, 1998, Int. J. Mol. Med., 1, 213
Cited by
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
“In particular, the specific activity of GATA-1 in eosinophils but not other GATA-1+ lineages (mast cells, megakaryocytes, and erythroid cells) appears to be mediated by a high-affinity palindromic (or double) GATA site (67).”
BackgroundEosinophils: Biological Properties and Role in Health and Disease
HOGAN, S. P., ROSENBERG, H. F., MOQBEL, R., PHIPPS, S., FOSTER, P. S., LACY, P., KAY, A. B., & ROTHENBERG, M. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02958.x · Cited by 834
“In most cell types, GATA-1 and PU.1 antagonize each other, but have synergistic activity in regulating eosinophil lineage specification (and eosinophil granule protein transcription) (Du et al. 2002).”
BackgroundInfluentialEosinophil trafficking in allergy and asthma
Rosenberg, H. F., Phipps, S., & Foster, P. S. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.048 · Cited by 428
The Biology of Eosinophils and Their Role in Asthma
McBrien, C. N., & Menzies-Gow, A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00093 · Cited by 368
“MBP can also trigger mast cells and basophils to release histamine, a potent mediator of bronchial hyperreactivity (72, 73).”
InfluentialEosinophilic and Noneosinophilic Asthma
Carr, T. F., Zeki, A. A., & Kraft, M. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2232pp · Cited by 351
“GATA-1 and PU.1 synergistically promote transcription of MBP (54).”
InfluentialChapter 3 Biology of the Eosinophil
Blanchard, C., & Rothenberg, M. E. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(08)01003-1 · Cited by 345
Eosinophils: multifaceted biological properties and roles in health and disease
Kita, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01026.x · Cited by 336
“1 synergistically induce eosinophil lineage differentiation (6).”
Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease
Viger, R. S., Guittot, S. M., Anttonen, M., Wilson, D. B., & Heikinheimo, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0513 · Cited by 270
Contributions of Eosinophils to Human Health and Disease
Klion, A. D., Ackerman, S. J., & Bochner, B. S. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032756 · Cited by 244
Self-citationGATA‐1 forms distinct activating and repressive complexes in erythroid cells
Rodriguez, P., Bonte, E., Krijgsveld, J., Kolodziej, K. E., Guyot, B., Heck, A. J., Vyas, P., de Boer, E., Grosveld, F., & Strouboulis, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600702 · Cited by 254
FOG‐1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA‐1
Hong, W., Nakazawa, M., Chen, Y., Kori, R., Vakoc, C. R., Rakowski, C., & Blobel, G. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600703 · Cited by 253
“Moreover, the methylated DNA-binding protein MBD-2 was not detected by Western blot, suggesting that FOG-1 recruits NuRD but not the MeCP-1 complex, which contains MBD2 in addition to NuRD (Ng et al, 1999; Zhang et al, 1999; Feng and Zhang, 2001).”
BackgroundMethodThe role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184
Hierarchical Differentiation of Myeloid Progenitors Is Encoded in the Transcription Factor Network
Krumsiek, J., Marr, C., Schroeder, T., & Theis, F. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022649 · Cited by 179
“1 and GATA-1 synergize in the development of the eosinophil lineage [37], whereas the mutual inhibition between PU.”
BackgroundEosinophil Survival and Apoptosis in Health and Disease
Park, Y. M., & Bochner, B. S. (2010) · Allergy, Asthma and Immunology Research · doi:10.4168/aair.2010.2.2.87 · Cited by 173
Uhm, T. G., Kim, B. S., & Chung, I. Y. (2012) · Allergy, Asthma and Immunology Research · doi:10.4168/aair.2012.4.2.68 · Cited by 170
“The complex includes interactions between GATA-1 and C/EBPα, GATA-1 and C/EBPβ, GATA-1 and C/EBPε isoforms, GATA-1 and PU.1, PU.1 and C/ EBPε isoforms, and GATA-1 and FOG.14,22,34,41 These findings establish a combinatorial cooperation and antagonism through protein–protein interactions of the transcription factors th…”
BackgroundInfluentialA Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma
Peters, M. C., Ringel, L., Dyjack, N., Herrin, R., Woodruff, P. G., Rios, C., O’Connor, B., Fahy, J. V., & Seibold, M. A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1291oc · Cited by 151
Roeder, I., & Glauche, I. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.01.021 · Cited by 142
“…between GATA-1 and PU.1 which induce a mutual inhibition and, therefore, favor one lineage choice at the expense of the other (erythroid/megakaryocyte vs. myeloid) (Du et al., 2002; Nerlov et al., 2000; Rekhtman et al., 1999, 2003; Voso et al., 1994; Yamada et al., 1998; Zhang et al., 1999, 2000).”
BackgroundMethodInfluentialEGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression
Wagner, L. A., Christensen, C., Dunn, D. M., Spangrude, G. J., Georgelas, A., Kelley, L. L., Esplin, M. S., Weiss, R. B., & Gleich, G. J. (2007) · Blood · doi:10.1182/blood-2006-06-027987 · Cited by 145
Eosinophils in the pathogenesis of allergic airways disease
Trivedi, S. G., & Lloyd, C. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6527-y · Cited by 156
“1 synergy and the functions of C/EBPα and C/EBPβ [13].”
BackgroundGraded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate
Chou, S. T., Khandros, E., Bailey, L. C., Nichols, K. E., Vakoc, C. R., Yao, Y., Huang, Z., Crispino, J. D., Hardison, R. C., Blobel, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-207944 · Cited by 143
Bakakos, A., Loukides, S., & Bakakos, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091375 · Cited by 129
“1, and CAAT enhancer-binding proteins α and ε [9].”
BackgroundMechanisms of Eosinophilia in the Pathogenesis of Hypereosinophilic Disorders
Ackerman, S. J., & Bochner, B. S. (2007) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2007.07.004 · Cited by 128
“lineage for transcription of genes such as MBP1 [34].”
BackgroundSelf-citationPathogenesis of eosinophilic chronic rhinosinusitis
Shah, S. A., Ishinaga, H., & Takeuchi, K. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0121-8 · Cited by 128
“Myeloid precursors are responsible for the formation of eosinophils in bone marrow in response to cytokine activation, and following an appropriate stimulus, they are released into the circulation [22].”
BackgroundInfluentialWhat targeting eosinophils has taught us about their role in diseases
Bochner, B. S., & Gleich, G. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.026 · Cited by 126
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
Howell, I., Howell, A., & Pavord, I. D. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221212 · Cited by 100
“IL-5, GM-CSF, and IL-3 synergistically continue this process of differentiation and maturation in the bone marrow (Du et al., 2002).”
BackgroundSputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma
Wang, G., Baines, K. J., Fu, J., Wood, L. G., Simpson, J. L., McDonald, V. M., Cowan, D. C., Taylor, D. R., Cowan, J. O., & Gibson, P. G. (2015) · European Respiratory Journal · doi:10.1183/13993003.01098-2015 · Cited by 80
Bedi, R., Du, J., Sharma, A. K., Gomes, I., & Ackerman, S. J. (2008) · Blood · doi:10.1182/blood-2008-02-139741 · Cited by 76
“The C/EBP- isoform or empty GFP vector-transduced cells were plated in duplicate or triplicate (750 CD34 GFP cells/chamber) and cultured using different cytokine cocktails to induce (1) mixed myeloid, (2) mixed myeloid plus erythroid, (3) eosinophil, (4) neutrophil, or (5) erythroid differentiation (Table 1).”
MethodSelf-citationGupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
“1 target genes/promoters such as the M-CSFR, suggesting a potent repressor function for this isoform in myeloid development [95].”
BackgroundTranscription factor PU.1 is expressed in white adipose and inhibits adipocyte differentiation
Wang, F., & Tong, Q. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00422.2007 · Cited by 65
“1 physically interacts with C/EBP family members, such as C/EBPε (7) and C/EBP (32).”
BackgroundGranulocytes: effector cells or immunomodulators in the immune response to helminth infection?
Cadman, E. T., & Lawrence, R. A. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01147.x · Cited by 56
Hudson, S. A., Herrmann, H., Du, J., Cox, P., Haddad, E., Butler, B., Crocker, P. R., Ackerman, S. J., Valent, P., & Bochner, B. S. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9589-4 · Cited by 55
“3D10 and AML14 lines were maintained in culture as previously described [22, 23].”
BackgroundSelf-citationEosinophil Development, Disease Involvement, and Therapeutic Suppression
Fulkerson, P. C., & Rothenberg, M. E. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.03.001 · Cited by 59
Transcription Factors in Eosinophil Development and As Therapeutic Targets
Fulkerson, P. C. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00115 · Cited by 53
“C/EBPε is important for the expression of secondary granules in both neutrophils and eosinophils (36, 37), and C/EBPε deficiency results in impaired functional responses for neutrophils (27).”
BackgroundKanda, A., Yun, Y., Bui, D. V., Suzuki, K., Sawada, S., Kobayashi, Y., Asako, M., & Iwai, H. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00892 · Cited by 59
IFN Consensus Sequence Binding Protein (Icsbp) Is Critical for Eosinophil Development
Milanovic, M., Terszowski, G., Struck, D., Liesenfeld, O., & Carstanjen, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5045 · Cited by 47
“At the molecular level, several studies have implicated Gata1 (6, 7), and the C/EBP family, notably (8), (9), and (10, 11) as critical transcriptional regulators of transcripts encoding typical proteins of the eosinophil as well as the formation of mature eosinophils.”
BackgroundEosinophils in the Field of Nasal Polyposis: Towards a Better Understanding of Biologic Therapies
Vanderhaegen, T., Gengler, I. M., Dendooven, A., Chenivesse, C., Lefèvre, G., & Mortuaire, G. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08844-7 · Cited by 51
Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis
Bouffi, C., Kartashov, A. V., Schollaert, K. L., Chen, X., Bacon, W. C., Weirauch, M. T., Barski, A., & Fulkerson, P. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500510 · Cited by 50
Brown, A. L., Wilkinson, C. R., Waterman, S. R., Kok, C. H., Salerno, D. G., Diakiw, S. M., Reynolds, B., Scott, H. S., Tsykin, A., Glonek, G. F. V., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206112 · Cited by 53
“* Known C/EBP target genes [72, 81–86].”
GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
Maroz, A., Stachorski, L., Emmrich, S., Reinhardt, K., Xu, J., Shao, Z., Käbler, S., Dertmann, T., Hitzler, J. K., Roberts, I. A. G., et al. (2013) · Leukemia · doi:10.1038/leu.2013.373 · Cited by 46
Bastie, J.-N., Balitrand, N., Guidez, F., Guillemot, I., Larghero, J., Calabresse, C., Chomienne, C., & Delva, L. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0412 · Cited by 47
The Eosinophil in Health and Disease: from Bench to Bedside and Back
Liao, W., Long, H., Chang, C. C.-C., & Lu, Q. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8507-6 · Cited by 46
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
Vatrella, A., Maglio, A., Pelaia, C., Ciampo, L., Pelaia, G., & Vitale, C. (2022) · Biomedicines · doi:10.3390/biomedicines10092181 · Cited by 40
“1), and the CCAAT-enhancing binding protein (c/EBP) family [36].”
BackgroundGombart, A. F., Krug, U. O., O’Kelly, J., An, E., Vegesna, V., & Koeffler, H. P. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504286 · Cited by 41
“In addition, expression of eosinophilic granule genes (eosinophil peroxidase and MBP) was impaired [12, 13].”
BackgroundMunthe‐Kaas, M. C., Gerritsen, J., Carlsen, K. H., Undlien, D. E., Egeland, T., Skinningsrud, B., Tørres, T., & Carlsen, K. L. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01327.x · Cited by 39
Serwas, N. K., Huemer, J., Dieckmann, R., Mejstříková, E., Garncarz, W., Litzman, J., Hoeger, B., Zapletal, O., Janda, A., Bennett, K. L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00588 · Cited by 38
Hematopoiesis and T‐cell specification as a model developmental system
Rothenberg, E. V., Kueh, H. Y., Yui, M. A., & Zhang, J. A. (2016) · Immunological Reviews · doi:10.1111/imr.12417 · Cited by 36
Ha, S.-D., Cho, W., DeKoter, R. P., & Kim, S. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010149 · Cited by 36
Eosinophil-derived CCL-6 impairs hematopoietic stem cell homeostasis
Zhang, C., Yi, W., Li, F., Du, X., Wang, H., Wu, P., Peng, C., Luo, M., Hua, W., Wong, C. C. L., et al. (2018) · Cell Research · doi:10.1038/cr.2018.2 · Cited by 35
Origin, regulation and physiological function of intestinal oeosinophils
Fulkerson, P. C., & Rothenberg, M. E. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.10.023 · Cited by 37
Ishihara, K., Hong, J., Zee, O., & Ohuchi, K. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705869 · Cited by 33
Transcription factor and cytokine regulation of eosinophil lineage commitment
Mack, E. A., & Pear, W. S. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000552 · Cited by 34
“1 is required at earlier stages for myeloid differentiation [38,40,41].”
BackgroundWada, T., Akagi, T., Muraoka, M., Toma, T., Kaji, K., Agematsu, K., Koeffler, H. P., Yokota, T., & Yachie, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402222 · Cited by 32
“Further investigation will be necessary to assess whether the DRS mutant also exhibits defective interaction with other transcription factors such as c-Myb, PML, p300, E2F1, and Rb (9, 16, 25, 26).”
BackgroundHalene, S., Gaines, P. C. W., Sun, H., Zibello, T., Lin, S., Khanna‐Gupta, A., Williams, S. C., Perkins, A. S., Krause, D. S., & Berliner, N. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.11.004 · Cited by 37
“1 function via protein-protein interactions.[50] Similarly, C/EBPε mediated repression of PU.”
Gombart, A. F., Grewal, J., & Koeffler, H. P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806516 · Cited by 32
“presses eosinophil major basic protein gene expression [25].”
Eosinophils and Purinergic Signaling in Health and Disease
Ferrari, D., Vuerich, M., Casciano, F., Longhi, M. S., Melloni, E., Secchiero, P., Zech, A., Robson, S. C., Müller, T., & Idzko, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01339 · Cited by 33
Bakakos, A., Rovina, N., & Bakakos, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083969 · Cited by 30
“1, and CAAT enhancer‐binding proteins α and ε [49].”
Qin, Y., Auh, S. L., Blokh, L., Long, C. G., Gagnon, I., & Hamann, K. J. (2007) · PubMed · Cited by 29
FIP1L1-PDGFRα Imposes Eosinophil Lineage Commitment on Hematopoietic Stem/Progenitor Cells
Fukushima, K., Matsumura, I., Ezoe, S., Tokunaga, M., Yasumi, M., Satoh, Y., Shibayama, H., Tanaka, H., Iwama, A., & Kanakura, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807489200 · Cited by 30
ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions
Germič, N., Hosseini, A., Stojkov, D., Oberson, K., Claus, M., Benarafa, C., Calzavarini, S., Angelillo‐Scherrer, A., Arnold, I. C., Mueller, A., et al. (2021) · Blood · doi:10.1182/blood.2020010208 · Cited by 27
Sourmeli, S., Kravariti, L., & Lecanidou, R. (2003) · Insect Biochemistry and Molecular Biology · doi:10.1016/s0965-1748(03)00027-4 · Cited by 26
mTOR complexes differentially orchestrates eosinophil development in allergy
Zhu, C., Xia, L., Li, F., Zhou, L., Weng, Q., Li, Z., Wu, Y., Mao, Y., Zhang, C., Wu, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25358-z · Cited by 23
Ishihara, K., Takahashi, A., Kaneko, M., Sugeno, H., Hirasawa, N., Hong, J., Zee, O., & Ohuchi, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.016 · Cited by 23
Cebp1 and Cebpβ transcriptional axis controls eosinophilopoiesis in zebrafish
Li, G., Sun, Y., Kwok, I., Yang, L., Wen, W., Huang, P., Wu, M., Li, J., Huang, Z., Liu, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45029-0 · Cited by 24
“However, among the four isoforms of the human C/EBP ε protein, mouse C/EBP ε is only similar with human C/EBP ε p32 and C/EBP ε p30 , which are all proven to be required for eosinophilopoiesis 40,41 .”
Uhm, T. G., Lee, S. K., Kim, B., Kang, J. H., Park, C., Rhim, T. Y., Chang, H. S., Kim, D.-J., & Chung, I. Y. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.4.022 · Cited by 21
“GATA-1 transactivates eosinophil-specific genes, including major basic protein (MBP), Charcot-Leyden crystal protein, and eosinophil-derived neurotoxin, by binding to functional GATA elements in their promoters (Dyer and Rosenberg, 2000; Du et al., 2002; Qiu et al., 2009).”
BackgroundYang, M., Eyers, F., Xiang, Y., Guo, M., Young, I. G., Rosenberg, H. F., & Foster, P. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097537 · Cited by 20
“1 and c/EBPe may provide essential signals for the maturation [24–26], other factors may also contribute to the differentiation.”
BackgroundInfluentialGross, S. A., Zheng, J. H., Le, A. T., Kerzic, P. J., & Irons, R. (2006) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0128-7 · Cited by 19
Lee, J. W., Kim, H., Hwang, J., Kim, Y. H., Lim, G. Y., Sohn, W., Yoon, S. R., Kim, J., Park, T. S., Oh, S. H., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.048 · Cited by 17
Olig2 is expressed late in human eosinophil development and controls Siglec-8 expression
Hwang, S. M., Uhm, T. G., Lee, S. K., Kong, S.-K., Jung, K. H., Binas, B., Chai, Y. G., Park, S., & Chung, I. Y. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0715-314rrr · Cited by 17
“C/EBP-e isoforms are expressed in eosinophils at midlate differentiation stages and take part in eosinophil differentiation and maturation, such as modulation of the MBP1 and IL5RA genes [14, 15].”
BackgroundEnos, M., Bancos, S., Bushnell, T. P., & Crispe, I. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3699 · Cited by 20
“For example, factors of the Ikaros family specifically favor differentiation down the lymphoid pathway (3), whereas other factors, such as GATA-1 and C/EBP , favor differentiation down the myeloid pathway (4, 5).”
BackgroundGordon, C. T., Fox, V., Najdovska, S., & Perkins, A. C. (2005) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2005.03.004 · Cited by 16
Kim, K., Hwang, S. M., Kim, S. M., Park, S. W., Jung, Y., & Chung, I. Y. (2017) · Immune Network · doi:10.4110/in.2017.17.6.410 · Cited by 15
Considerations on the evolutionary biology and functions of eosinophils: what the “haeckel”?
Ackerman, S. J., & Stacy, N. I. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae109 · Cited by 13
Self-citationKim, B., Uhm, T. G., Lee, S. K., Lee, S.-H., Kang, J. H., Park, C., & Chung, I. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001037 · Cited by 14
Ohmori, S., Ishijima, Y., Numata, S., Takahashi, M., Sekita, M., Sato, T., Chugun, K., Yamamoto, M. P., & Ohneda, K. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00314-19 · Cited by 17
“1 synergistically activate the major basic protein P2 promoter in eosinophils (16), and in mast cells and basophils, GATA2 and PU.”
BackgroundMechanism of the Eosinophilic Differentiation of HL-60 Clone 15 Cells Induced by n-Butyrate
Ishihara, K., Hong, J., Zee, O., & Ohuchi, K. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000085436 · Cited by 12
Felton, J. M., Vallabh, S., Parameswaran, S., Edsall, L., Ernst, K., Wronowski, B., Malik, A., Kotliar, M., Weirauch, M. T., Barski, A., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000207 · Cited by 11
Muraoka, M., Akagi, T., Ueda, A., Wada, T., Koeffler, H. P., Yokota, T., & Yachie, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.130 · Cited by 9
Hyperéosinophilies et syndromes hyperéosinophiliques
Kahn, J., Legrand, F., Capron, M., & Prin, L. (2011) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(11)52510-5 · Cited by 10
Laffey, K. G., Du, J., Schrum, A. G., & Ackerman, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910245 · Cited by 7
Self-citationKong, S.-K., Kim, B., Uhm, T. G., Lee, W., Lee, G. R., Park, C., Lee, C., & Chung, I. Y. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203542 · Cited by 7
“K562 cells are known to abundantly express GATA-1 mRNA and protein and GATA-2 mRNA (14, 39, 40), but expression of GATA-2 protein has not been reported.”
BackgroundZhang, F., Zhu, Y., Deng, W. L., Zhu, J., & Zhang, J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0316-116r · Cited by 5
“C/EBPe-p27, which contains a unique N-terminal repression domain, acts as a transrepressor in eosinophil differentiation [34, 35].”
BackgroundCollini, V., Burelli, M., Favaretto, V., Pegolo, E., Fumarola, F., Lepre, V., Pellin, L., Taurian, M., Quartuccio, L., Imazio, M., et al. (2023) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.23.06287-7 · Cited by 5
The signaling mechanism of eosinophil activation
Gorska, M. M., & Alam, R. (2005) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.1.2.247 · Cited by 4
Stankiewicz, M. J., Du, J., Martinico, D., & Ackerman, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312689 · Cited by 4
“C/EBPε responsible for neutrophil specific granule deficiency [7,8], which also includes a deficiency in eosinophil development [9], demonstrate an essential role for the C/EBPε32 isoform in the terminal differentiation and maturation of granulocytes in both mice and humans, and the ability of this transcription facto…”
BackgroundMethodResultInfluentialSelf-citationFillon, S., Ackerman, S. J., & Furuta, G. T. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.009 · Cited by 3
Self-citationAn introduction to eosinophils and their biology
Ackerman, S. J. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10029020 · Cited by 3
Self-citationSquillace, D. L., Checkel, J. L., Tefferi, A., Kita, H., & Gleich, G. J. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.113015 · Cited by 3
The Cellular and Molecular Mechanisms of Hematopoiesis
Rankin, E. B., & Sakamoto, K. M. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_1 · Cited by 3
Hu, C., Li, J., Yuan, Y., & Jin, R. (2025) · PubMed · doi:10.7499/j.issn.1008-8830.2408143 · Cited by 2
Wolff, L., Ackerman, S. J., & Nucifora, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.12.018 · Cited by 2
Self-citationChoe, Y. H., & Lee, Y. C. (2008) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2008.64.1.1 · Cited by 2
Ellis, A. K., Ackerman, S. J., Crawford, L., Du, J., Bedi, R., & Denburg, J. A. (2010) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2010.01003.x · Cited by 2
“GATA-1 is not only necessary and sufficient for eosinophilopoiesis (20), it has been clearly established as a pivotal transcription factor for eosinophil lineage specification, as revealed by the loss of the eosinophil lineage in mice harboring a targeted transgenic deletion of the high-affinity GATA-binding site in t…”
BackgroundSelf-citationCytokine networks driving eosinophil functional heterogeneity
King, J. I., & Arnold, I. C. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.100347 · Cited by 1
ID2 Unlocks retinoic acid signaling to promote eosinophil maturation by antagonizing TCF3
Huang, Y., Wen, H., Li, J., Li, G., & Zhang, Y. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117789 · Cited by 1
Le polynucléaire éosinophile : nouveautés en physiologie et implications diagnostiques
Prin, L., Gatault, S., Lefèvre, G., & Kahn, J. (2014) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(14)72481-5 · Cited by 2
(2012) · Elsevier eBooks · doi:10.1016/b978-0-12-394385-9.00005-5 · Cited by 3
Rothenberg, M. E. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50041-3 · Cited by 2
Wolff, L., Ackerman, S. J., & Nucifora, G. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.09.011 · Cited by 1
Self-citationFractionation of Mature Eosinophils in GATA-Reporter Transgenic Mice
Kim, K., Suzuki, N., Ohneda, K., Minegishi, N., & Yamamoto, M. P. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.220.127 · Cited by 2
L’éosinophile : de la physiologie à la démarche diagnostique
Kahn, J., Ackermann, F., Prin, L., Capron, M., Legrand, F., & Blétry, O. (2011) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(11)70024-6 · Cited by 1
Metadata
- Authors
- Du, J., Stankiewicz, M. J., Liu, Y., Xi, Q., Schmitz, J. E., Lekstrom-Himes, J. A., & Ackerman, S. J.
- Affiliations
- University of Illinois Chicago (US)
- National Institutes of Health (US)
- Corresponding author
- Ackerman, Steven J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 45
- Pages
- 43481-43494
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1986849847
- Semantic Scholar
- 996be5614218ca95d98ba6774ca1695690200b9a
- Cited by
- 120
- References
- 107
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 7
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6559 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of Illinois at Urbana-Champaign
- U.S. Public Health Service
- University of Illinois at Chicago
- National Institute of Allergy and Infectious Diseases (R01AI033043, AI 33043)
- National Center for Research Resources (M01RR013987)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- GATA-1, PU.1, major basic protein, eosinophils, transcriptional regulation, protein-protein interaction, transcriptional synergy, transcriptional repression, P2 promoter, eosinophil progenitors
- MeSH terms
- Proto-Oncogene Protein Spi-1, Base Sequence, Blood Donors, Blood Proteins, Cell Nucleus, DNA-Binding Proteins, Eosinophils, Gene Expression Regulation, Humans, Promoter Regions, Genetic, Proto-Oncogene Proteins, Ribonucleases, Transcription Factors, Trans-Activators, Mutagenesis, Leucine Zippers, Consensus Sequence, Sequence Deletion, Protein Isoforms, 5' Untranslated Regions, CCAAT-Enhancer-Binding Proteins, Eosinophil Granule Proteins, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.